Haleon PLC Sponsored ADR (NYSE:HLN) Given Average Rating of “Moderate Buy” by Brokerages

Haleon PLC Sponsored ADR (NYSE:HLN) has been assigned an average rating of “Moderate Buy” from the nine research firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $12.3250.

Several research firms recently commented on HLN. Hsbc Global Res upgraded shares of Haleon from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, January 21st. Morgan Stanley reiterated an “overweight” rating on shares of Haleon in a research note on Monday, December 15th. Deutsche Bank Aktiengesellschaft lowered Haleon from a “hold” rating to a “sell” rating in a report on Monday, January 12th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Haleon in a research report on Tuesday, January 20th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Haleon in a research report on Thursday, January 22nd.

Haleon Stock Up 0.6%

HLN stock opened at $10.44 on Wednesday. Haleon has a fifty-two week low of $8.71 and a fifty-two week high of $11.42. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.87 and a quick ratio of 0.63. The stock has a market capitalization of $46.47 billion, a price-to-earnings ratio of 26.76 and a beta of 0.19. The business’s fifty day moving average price is $9.89 and its two-hundred day moving average price is $9.61.

Institutional Trading of Haleon

Several institutional investors and hedge funds have recently modified their holdings of the business. Archford Capital Strategies LLC acquired a new position in Haleon in the third quarter valued at $2,149,000. New York State Common Retirement Fund bought a new stake in shares of Haleon during the 2nd quarter valued at about $3,964,000. Acadian Asset Management LLC grew its stake in Haleon by 3,031.5% during the second quarter. Acadian Asset Management LLC now owns 5,384,661 shares of the company’s stock worth $55,813,000 after purchasing an additional 5,212,711 shares during the period. JTC Employer Solutions Trustee Ltd increased its holdings in Haleon by 120.7% in the third quarter. JTC Employer Solutions Trustee Ltd now owns 712,229 shares of the company’s stock worth $6,392,000 after purchasing an additional 389,467 shares in the last quarter. Finally, Arlington Partners LLC lifted its stake in Haleon by 128.0% in the third quarter. Arlington Partners LLC now owns 508,886 shares of the company’s stock valued at $4,565,000 after buying an additional 285,692 shares during the period. 6.67% of the stock is currently owned by institutional investors.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.